Skip to main content
VCbacked
Log inGet Started

Anebulo Pharmaceuticals

Austin, United States

Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.

$994K raised
Sep 2025
Grant
BiotechnologyLife SciencemHealth

Top Investors

Merida Capital HoldingsNational Institute on Drug Abuse (NIDA)22NWLP

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anebulo Pharmaceuticals

How much funding has Anebulo Pharmaceuticals raised?
Anebulo Pharmaceuticals has raised $994K in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Who are Anebulo Pharmaceuticals's investors?
Anebulo Pharmaceuticals's investors include Merida Capital Holdings, National Institute on Drug Abuse (NIDA), 22NW, LP.
Where is Anebulo Pharmaceuticals headquartered?
Anebulo Pharmaceuticals is headquartered in Austin, United States.
What does Anebulo Pharmaceuticals do?
Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
What stage is Anebulo Pharmaceuticals at?
Anebulo Pharmaceuticals is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Anebulo Pharmaceuticals — Funding & Investors." VCBacked, September 2, 2025, https://www.vcbacked.co/company/anebulo-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Anebulo Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/anebulo-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Anebulo Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/anebulo-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K